Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (1): 21-26    DOI: 10.19485/j.cnki.issn2096-5087.2023.01.005
  论著 本期目录 | 过刊浏览 | 高级检索 |
义乌市2016—2020年报告HIV/AIDS病例流动特征分析
蒋均1, 陈军仙2, 楼莲娟2, 朱碧香2, 查琏琦2, 阮建军2
1.浙江省疾病预防控制中心艾滋病与性病预防控制所,浙江 杭州 310051;
2.义乌市疾病预防控制中心,浙江 义乌 322000
Migration characteristics among HIV/AIDS patients reported in Yiwu City from 2016 to 2020
JIANG Jun1, CHEN Junxian2, LOU Lianjuan2, ZHU Bixiang2, ZHA Lianqi2, RUAN Jianjun2
1. Department of HIV/AIDS and STDS Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China;
2. Yiwu Center for Disease Control and Prevention, Yiwu, Zhejiang 322000, China
全文: PDF(912 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解浙江省义乌市2016—2020年报告艾滋病病毒感染者和艾滋病患者(HIV/AIDS)确证后流动及随访治疗情况,为优化流动人口艾滋病防控策略提供依据。方法 通过中国疾病预防控制信息系统艾滋病综合防治信息系统收集义乌市2016—2020年报告HIV/AIDS病例的人口学、随访和治疗资料,分析HIV/AIDS病例确证后流动特征、抗病毒治疗和转归情况,并采用Cox比例风险回归模型分析HIV/AIDS病例确证后流动的影响因素。结果 义乌市2016—2020年报告的1 189例HIV/AIDS病例纳入分析。男性988例,占83.10%;非浙江省户籍806例,占67.79%。流出义乌市441例,占37.09%,流动率为17.73/100人年;其中流出浙江省366例,跨省流动比例为30.78%。非浙江省户籍病例中,流出义乌市395例,占49.01%;其中返回户籍省份337例,占85.32%,以云南省、四川省、贵州省和湖南省为主。少数民族(HR=1.375,95%CI:1.044~1.811)、离退休人员(HR=3.605,95%CI:1.771~7.335)、学生(HR=8.969,95%CI:4.095~19.645)、非浙江省户籍(HR=4.545,95%CI:3.164~6.529)、经流动人口或从业人口体检发现(HR=1.318,95%CI:1.006~1.727)的病例确证后流动的可能性较高;已婚有配偶(HR=0.721,95%CI:0.569~0.913)、初中及以上学历(HR:0.428~0.753,95%CI:0.280~0.952)的病例确证后流动的可能性较低。流动病例中,失访26例,占5.90%;死亡49例,占11.11%。流动病例未接受抗病毒治疗、由HIV感染者进展为AIDS患者和病毒未抑制的比例均高于未流动病例(P<0.05)。结论 义乌市2016—2020年报告的HIV/AIDS病例中,非浙江省户籍、未婚、文化程度较低、离退休人员、学生、经流动人口或从业人员体检发现病例确证后流动风险较高,且流动不利于抗病毒治疗和随访的延续性,可影响疾病转归。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
蒋均
陈军仙
楼莲娟
朱碧香
查琏琦
阮建军
关键词 艾滋病流动人口随访抗病毒治疗    
AbstractObjective To investigate the migration characteristics and follow-up treatment among HIV/AIDS patients after HIV confirmation in Yiwu City, Zhejiang Province from 2016 to 2020, so as to provide insights into the optimization of the HIV/AIDS control strategy among floating populations. Methods The reported HIV/AIDS patients' demographics, follow-up and treatment data in Yiwu City from 2016 to 2020 were captured from the HIV/AIDS Prevention and Control Information System of Chinese Disease Control and Prevention Information System. The migration characteristics, antiretroviral therapy and outcomes of HIV/AIDS patients were analyzed after HIV confirmation, and the factors affecting the migration of HIV/AIDS patients after HIV confirmation were identified using a Cox proportional hazard regression model. Results A total of 1 189 HIV/AIDS patients were enrolled, including 988 men (83.10%) and 806 cases without Zhejiang provincial household registration (67.79%). There were 441 patients (37.09%) migrating out of Yiwu City after HIV confirmation, with a migration rate of 17.73/100 person-years, and there were 366 patients migrating out of Zhejiang Province, with a cross-province migration rate of 30.78%. Among participants without Zhejiang provincial household registration, 395 patients (49.01%) migrated out of Yiwu City, including 337 patients (85.32%) returning to their household registration provinces, which mainly included Yunnan, Sichuan, Guizhou and Hunan. Cox proportional hazard regression analysis showed a high risk of migration among minority ethnic populations (HR=1.375, 95%CI: 1.044-1.811), retires (HR=3.605, 95%CI: 1.771-7.335), students (HR=8.969, 95%CI: 4.095-19.645), patients without Zhejiang provincial household registration (HR=4.545, 95%CI: 3.164-6.529) and patients identified through physical examination of floating populations or employees (HR=1.318, 95%CI: 1.006-1.727), and a low risk among married patients with spouses (HR=0.721, 95%CI: 0.569-0.913) and with an educational level of junior high school and above (HR: 0.428~0.753, 95%CI: 0.280-0.952). Among all floating HIV/AIDS patients, there were 26 cases lost to follow-up (5.90%) and 49 deaths (11.11%). In addition, the proportion of absence of antiretroviral therapy, HIV infection progressing into AIDS patients and failure in HIV inhibition were all greater among floating HIV/AIDS patients than among non-floating patients (P<0.05). Conclusions A high risk of migration was found among HIV/AIDS patients without Zhejiang provincial household registration, unmarried patients, patients with a low education level, retirees, students, and patients identified through physical examination of floating populations or employees in Yiwu City from 2016 to 2020, and migration does not facilitate the sustainability of antiretroviral therapy and follow-up, which may affect the prognosis of HIV/AIDS.
Key wordsAIDS    floating population    follow-up    antiretroviral therapy
收稿日期: 2022-10-20      修回日期: 2022-11-29      出版日期: 2023-01-10
中图分类号:  R512.91  
作者简介: 蒋均,硕士,主管医师,主要从事艾滋病预防控制工作
通信作者: 阮建军,E-mail:464094921@qq.com   
引用本文:   
蒋均, 陈军仙, 楼莲娟, 朱碧香, 查琏琦, 阮建军. 义乌市2016—2020年报告HIV/AIDS病例流动特征分析[J]. 预防医学, 2023, 35(1): 21-26.
JIANG Jun, CHEN Junxian, LOU Lianjuan, ZHU Bixiang, ZHA Lianqi, RUAN Jianjun. Migration characteristics among HIV/AIDS patients reported in Yiwu City from 2016 to 2020. Preventive Medicine, 2023, 35(1): 21-26.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.01.005      或      https://www.zjyfyxzz.com/CN/Y2023/V35/I1/21
[1] 张涛,孙立奇,李书婷,等.我国公共卫生资源配置的公平与效率分析——基于HRAD和DEA的研究[J].中国卫生政策研究,2017,10(9):57-62.
[2] CASSELS S,JENNESS S M,KHANNA A S.Conceptual framework and research methods for migration and HIV transmission dynamics[J].AIDS Behav,2014,18(12):2302-2313.
[3] 刘丹,张燕,奉水东,等.深圳市2012—2017年新报告HIV/AIDS病例特征分析[J].预防医学,2019,31(5):511-513.
[4] 杨薇,赖文红,袁业伟,等.四川省艾滋病病毒感染者和患者异地流动以及随访检测与治疗现状分析[J].预防医学情报杂志,2020,36(12):1561-1571.
[5] 义乌市统计局,义乌市人民政府第七次人口普查领导小组办公室.义乌市第七次人口普查主要数据公报[R].2021.
[6] 韩晶,李健,臧春鹏,等.我国2016—2018年报告HIVAIDS首次随访后跨省流动情况和抗病毒治疗效果分析[J].中华流行病学杂志,2021,42(1):126-130.
[7] 史宏博,洪航,董红军.浙江省宁波市HIV/AIDS流动病例的流行病学特征分析[J].疾病监测,2018,33(10):835-838.
[8] 关云琦,张梅,张笑,等.中国就业流动人口就医行为及其影响因素分析[J].中华流行病学杂志,2019,40(3):301-308.
[9] 李洪权,冯来强.2009—2011年北京市流动人口传染病流行特征[J].中华预防医学,2013,47(5):479-480.
[10] 刘涛,史秋洁.新冠肺炎疫情扩散时空图谱:人口流动新趋势与防控机制新挑战[EB/OL].[2022-11-29].https://mp.weixin.qq.com/s/_FHfABsHqTaTTmyDg-mFHQ.
[11] 查琏琦,楼莲娟,阮建军,等.义乌市新报告≥50岁HIV/AIDS病例特征分析[J].预防医学,2021,33(5):511-513.
[12] ZHANG J,YAO J,JIANG J,et al.Migration interacts with the local transmission of HIV in developed trade areas:a molecular transmission network analysis in China[J/OL].Infect Genet Evol,2020,84(48)[2022-11-29].http://doi.org/10.1016/j.meegid.2020.104376.
[13] 谭诗文,史宏博,姜海波,等.2011—2021年宁波市15~24岁HIV/AIDS病例特征分析[J].预防医学,2022,34(11):1105-1109.
[14] 卓玛拉措,曾亚莉,李菊梅,等.2018年四川省HIV/AIDS病人随访检测的影响因素[J].中国艾滋病性病,2020,26(10):1072-1075.
[15] 甘秀敏,马烨,豆智慧,等.中国2011—2015年跨省流动HIVAIDS免费抗病毒治疗现状及影响因素分析[J].中华流行病学杂志,2018,39(9):1234-1238.
[16] 单士馨,山东省2014—2015年HIV感染者/艾滋病患者耐药状况及其影响因素研究[D].济南:济南大学,2018.
[1] 徐光明, 张震, 叶小红. 2015—2024年临海市新报告HIV/AIDS病例晚发现及影响因素分析[J]. 预防医学, 2026, 38(1): 71-74.
[2] 苏德华, 陈向阳, 李君, 赵丽娜, 张鹤美, 朱婷婷, 胡文雪, 赖江宜. 温州市新报告HIV/AIDS病例抗病毒治疗及时性分析[J]. 预防医学, 2025, 37(8): 804-808.
[3] 徐莉, 刘萍, 卞宇旬, 陈圆媛, 李鑫娜, 周乐. 扬州市新报告50岁及以上HIV/AIDS病例抗病毒治疗前耐药分析[J]. 预防医学, 2025, 37(8): 779-782,788.
[4] 李瑶, 杨景元, 杨虹, 李向春, 孔瑞琴, 刘静, 白宝宝, 张艳萍, 李慧. 内蒙古自治区艾滋病自愿咨询检测门诊求询者特征分析[J]. 预防医学, 2025, 37(4): 356-360.
[5] 李倩, 杨柏林, 陈积标, 尹寒露, 许祝平, 孟晓军. 无锡市50岁及以上HIV/AIDS抗病毒治疗病例自报慢性病资料分析[J]. 预防医学, 2025, 37(4): 390-394.
[6] 王洪岩, 任飞林, 刘小琦, 金玫华, 吴振乾. 2009—2023年湖州市HIV/AIDS病例新发现率趋势分析[J]. 预防医学, 2025, 37(4): 395-399.
[7] 王苓, 许珂, 张兴亮, 黄思超, 李西婷, 陈珺芳. 2022年杭州市新报告HIV/AIDS病例感染特征分析[J]. 预防医学, 2025, 37(2): 123-129.
[8] 钟郁媛, 许鑫慧, 王嘉川, 门娅玲, 李羽恒, 顾仁君, 王红妹. 老年HIV/AIDS病例心理弹性在艾滋病相关压力与患者报告结局间的中介效应分析[J]. 预防医学, 2025, 37(12): 1189-1194.
[9] 杨文涛, 张宏, 朱士玉, 徐娜, 杨志远, 朱建明, 宋灿磊. HIV/AIDS病例生存质量的影响因素研究[J]. 预防医学, 2025, 37(12): 1195-1200.
[10] 丁晨, 刘家虹, 吴争, 熊长辉. 江西省部分地区HIV/AIDS病例HIV-1分子传播网络分析[J]. 预防医学, 2024, 36(9): 764-767.
[11] 戴色莺, 沈月兰, 刘爱文, 张进, 吴家兵. 安徽省男性流动人口艾滋病相关知识和HIV感染情况调查[J]. 预防医学, 2024, 36(8): 674-678,682.
[12] 王慧, 李锦成, 陆兴, 王金富, 竺丽梅, 刘巧. 重组结核杆菌融合蛋白皮肤试验筛查HIV/AIDS病例结核分枝杆菌潜伏感染的效果分析[J]. 预防医学, 2024, 36(7): 639-643.
[13] 何婷婷, 曹栋卿, 林家锋, 蒋卓婧, 张佳峰, 范钦. 绍兴市MSM人群HIV-1分子传播网络特征分析[J]. 预防医学, 2024, 36(7): 571-575,579.
[14] 吴斌, 方琼楼, 朱珂. 金华市抗病毒治疗失败HIV/AIDS病例HIV-1亚型及耐药分析[J]. 预防医学, 2024, 36(6): 506-509.
[15] 贾晓锋, 王慧群, 石敏, 汤婕, 任静霞. HIV/AIDS病例HIV相关神经认知障碍的影响因素分析[J]. 预防医学, 2024, 36(6): 461-464.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed